Article
Prevalence of K-Ras mutations in hepatocellular carcinoma: A Turkish Oncology Group pilot study
31 Aug 2015
Abstract excerpt
Hepatocellular carcinoma (HCC) is the fifth most common male-predominant type of cancer worldwide. There is no effective treatment regimen available for advanced-stage disease and chemotherapy is generally ineffective in these patients. The number of studies on the prevalence of K-Ras mutations in HCC patients is currently limited. A total of 58 patients from 6 comprehensive cancer centers in 4 metropolitan...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
